Gene-environment interactions in Parkinson's disease: the importance of animal modeling
- PMID: 20811350
- PMCID: PMC3085510
- DOI: 10.1038/clpt.2010.138
Gene-environment interactions in Parkinson's disease: the importance of animal modeling
Abstract
Parkinson's disease (PD), a late-onset neurodegenerative disorder, occurs most commonly in a "sporadic" (idiopathic) form, without a clearly defined genetic basis and only a vaguely delineated pathogenesis. Together, the various monogenic forms of PD (i.e., those arising from mutations in single genes) account for a minority of PD cases but have provided crucial insights into disease mechanisms. Although it is commonly believed that sporadic PD is caused by a lifetime of environmental exposures that are superimposed on an individual's composite genetic susceptibility, this hypothesis has not been tested adequately. This article reviews genetic and environmental factors that have been associated with PD and attempts to put these into a pathogenic framework. We argue that animal modeling will become increasingly important in attempting to elucidate gene-environment interactions, to define pathogenic mechanisms, and to provide a platform for testing of targeted therapeutic interventions.
Similar articles
-
Gene-environment interactions in Parkinson's disease.Parkinsonism Relat Disord. 2007;13 Suppl 3:S309-15. doi: 10.1016/S1353-8020(08)70022-1. Parkinsonism Relat Disord. 2007. PMID: 18267256 Review.
-
Gene-environment interaction and Mendelian randomisation.Rev Neurol (Paris). 2019 Dec;175(10):597-603. doi: 10.1016/j.neurol.2019.04.010. Epub 2019 Sep 19. Rev Neurol (Paris). 2019. PMID: 31543362 Review.
-
Environmental toxins and Parkinson's disease.Annu Rev Pharmacol Toxicol. 2014;54:141-64. doi: 10.1146/annurev-pharmtox-011613-135937. Epub 2013 Sep 16. Annu Rev Pharmacol Toxicol. 2014. PMID: 24050700 Review.
-
Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.J Neurol Sci. 2011 Jul 15;306(1-2):1-8. doi: 10.1016/j.jns.2011.04.005. Epub 2011 Apr 21. J Neurol Sci. 2011. PMID: 21513949 Review.
-
[Epidemiology and causes of Parkinson's disease].Nervenarzt. 2017 Apr;88(4):345-355. doi: 10.1007/s00115-017-0288-0. Nervenarzt. 2017. PMID: 28289797 Review. German.
Cited by
-
Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.Sci Rep. 2019 Sep 24;9(1):13759. doi: 10.1038/s41598-019-50256-3. Sci Rep. 2019. PMID: 31551498 Free PMC article.
-
Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease.J Neuroinflammation. 2011 Aug 24;8:105. doi: 10.1186/1742-2094-8-105. J Neuroinflammation. 2011. PMID: 21864400 Free PMC article.
-
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.PLoS One. 2011;6(8):e23660. doi: 10.1371/journal.pone.0023660. Epub 2011 Aug 17. PLoS One. 2011. PMID: 21858193 Free PMC article.
-
Convergent pathways in Parkinson's disease.Cell Tissue Res. 2018 Jul;373(1):79-90. doi: 10.1007/s00441-017-2700-2. Epub 2017 Oct 23. Cell Tissue Res. 2018. PMID: 29063175 Free PMC article. Review.
-
Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.Antioxid Redox Signal. 2012 Dec 15;17(12):1676-93. doi: 10.1089/ars.2011.4474. Epub 2012 Sep 14. Antioxid Redox Signal. 2012. PMID: 22816731 Free PMC article.
References
-
- Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009;18:R48–R59. - PubMed
-
- Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C. The genetics of Parkinson's syndromes: a critical review. Curr. Opin. Genet. Dev. 2009;19:254–265. - PubMed
-
- Polymeropoulos MH, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045–2047. - PubMed
-
- Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. - PubMed
-
- Lundvig D, Lindersson E, Jensen PH. Pathogenic effects of alpha-synuclein aggregation. Brain Res. Mol. Brain Res. 2005;134:3–17. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical